TELOMERE LENGTH, TELOMERASE ACTIVITY, HEART RATE VARIABILITY, OR OXIDATIVE STRESS: WHICH ONE IS MOST ASSOCIATED WITH

M Cherska1, D Krasnienkov2, N Tronko3

  • 11The State Institution "V.P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Insights

Markers of oxidative stress and heart rate variability (HRV) can help assess atherothrombotic stroke risk in older adults. Higher sympathetic nervous system activity was noted in patients with cerebral atherosclerosis.

Area of Science:

  • Cardiovascular Research
  • Neurology
  • Biomarkers

Background:

  • Cerebral Atherosclerosis (CA) is a significant risk factor for stroke.
  • Oxidative stress and Heart Rate Variability (HRV) are implicated in cardiovascular diseases.
  • Understanding their role in CA patients is crucial for risk stratification.

Purpose of the Study:

  • To evaluate the impact of oxidative stress markers and HRV on stroke risk in patients with Cerebral Atherosclerosis.
  • To compare these markers between patients with CA and those who have experienced ischemic stroke.

Main Methods:

  • A prospective study of 84 patients diagnosed with Cerebral Atherosclerosis.
  • Patients were divided into two groups: those with ischemic stroke (IS) and those with CA (1-2 degrees).
  • Assessment included clinical, laboratory, and instrumental examinations, focusing on HRV (LF/HF ratio) and oxidative stress markers.

Main Results:

  • Patients with CA showed a predominance of sympathetic nervous system tone (higher LF/HF ratio).
  • Markers of oxidative stress were comparable between groups, except for higher GSH in post-stroke patients.
  • HRV indices (HF, LF, VLF) were elevated in the CA group.

Conclusions:

  • Oxidative stress markers combined with HRV indices are valuable for assessing atherothrombotic stroke risk in the elderly.
  • Sympathetic nervous system predominance is observed in patients with Cerebral Atherosclerosis.
  • Further longitudinal studies with larger sample sizes are needed to clarify the links between oxidative stress, HRV, and stroke.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
779
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
506
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
261
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
363
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
270